Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is recruiting in South Korea. It is testing abilify® Tablet(Aripiprazole) for depression in bipolarity.
In SeoulThis study is recruiting in the United States, in Argentina, in Brazil, .... It is testing brenipatide for Bipolarity.
Multiple locations, including Orange
This study is recruiting in the United Kingdom. It is testing home-use brain stimulation to treat Depression for depression in bipolarity.
In United KingdomThis study is recruiting in South Korea. It is testing olanzapine for Bipolarity.
In SeongnamThis study is recruiting in Italy. It focuses on Bipolarity.
In MilanThis study is recruiting. It focuses on schizophrenia and currently lists participation information in China.
In ShanghaiThis study is recruiting in the United States. It is testing adverse Events and Change for Bipolarity.
Multiple locations, including HuntsvilleThis study is recruiting in the United States and in Russian Federation. It is testing change for depression.
Multiple locations, including BentonvilleThis study is recruiting in the United States, in Australia, in France, .... It is testing KarXT for manic episodes in bipolarity type I.
Multiple locations, including GlendaleThis study is recruiting in the United States. It focuses on adults with tardive dyskinesia who remain symptomatic while receiving or after stopping a VMAT2 inhibitor.
Multiple locations, including BryantThis study is recruiting in the United States, in France, in Argentina, .... It is testing KarXT for manic episodes in bipolarity type I, including participants taking lithium, valproate, or lamotrigine.
Multiple locations, including BentonvilleThis study is recruiting in the United States, in Australia, in New Zealand, .... It is testing KarXT for manic episodes in bipolarity type I.
Multiple locations, including Bentonville